As explained in the introduction section, studies have shown that nanoparticles targeted with folic acid enter prostate cancer cells through PSMA [26], and since methotrexate is an analog of folic acid, it can increase the absorption of nanoparticles through this route. This evidence concerns the gene FOLH1 and prostate carcinoma.